Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Opioid Prescriptions Are Still Prolific, But Deaths Fall

76 billion opioid pain pills distributed between 2012 and 2016.

FDA Approves Hadlima (Adalimumab-bwwd) Biosimilar

TNF blocker biosimilar to Humira (adalimumab, Abbvie).

Vaccinations in the Pipeline

C. Difficile, Influenza, Pneumococcal, and Meningococcal Updates

Read more

Reclaim your time. Reengineer your pharmacy’s path to success.

Meeting regulatory demands and ensuring that your pharmacy is compliant with payer requirements can be very time-consuming. Learn about time-saving solutions from Arete Pharmacy Network

here»

Shingles Complications in the Elderly

10 Ways to Boost Customer Loyalty

Pharmacists Among Those Fired in Hospital Fentanyl Deaths Case

Health System Specialty Pharmacies Enhance Services and Savings

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.